The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, By Roots Analysis
Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently …
Read MoreIn silico drug revelation administrations market is probably going to be worth USD 124 million by 2030, developing at an annualized pace of 15.6%, claims Roots Analysis
Owing to their cost and time-saving potential, in silico tools are widely used in modern pharmacological research; several companies have …
Read MoreThe blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis
Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ …
Read MoreThe ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis
Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities …
Read More